15.6 F
New York
Saturday, January 15, 2022

Pfizer developing vaccine that targets omicron; Chicago set to resume in-person classes: COVID-19 updates

Pfizer’s CEO Albert Bourla said developing a specifically designed to target the omicron is “the most likely scenario.” Updates.

Pfizer’s CEO Albert Bourla said developing a specifically designed to target the omicron is “the most likely scenario.” Updates.

Source : Latest Health News & Headlines | USA Today Read More

Related Articles

Leave a Reply

[td_block_social_counter style="style8 td-social-boxed td-social-font-icons" tdc_css="eyJhbGwiOnsibWFyZ2luLWJvdHRvbSI6IjM4IiwiZGlzcGxheSI6IiJ9LCJwb3J0cmFpdCI6eyJtYXJnaW4tYm90dG9tIjoiMzAiLCJkaXNwbGF5IjoiIn0sInBvcnRyYWl0X21heF93aWR0aCI6MTAxOCwicG9ydHJhaXRfbWluX3dpZHRoIjo3Njh9" custom_title="Stay Connected" block_template_id="td_block_template_8" f_header_font_family="712" f_header_font_transform="uppercase" f_header_font_weight="500" f_header_font_size="17" border_color="#dd3333"]
- Advertisement -

Trends Now

- Advertisement -

Latest Articles